Partnerships and Outlicensing

Meros advanced formulation technology can generate unique, targeted therapies, creating competitive advantage via product line extensions, adding value to older drugs and improving new compounds that show marginal performance on their own.

The Meros technology is available for collaborative development and outlicensing.

 

Contact Meros today to discuss how smart formulations can improve the performance of your therapeutic compounds.

Meros technology is covered by the following patents:

Country
Patent No.
Patent No.
United States
8,309,515
9,139,553
Canada
2,646,425
2,857,023
United Kingdom
1994081UK
2730604UK
France
1994081FR
2730604FR
Switzerland
1994081CH
2730604CH
Germany
602007036834
602007056634.7
Japan
5933889

Novel Poly(ethylene oxide)-Block-Poly(ester)
Block Copolymers